Business Description
Immunovant is a New York-based medical research company focused on developing new treatments for autoimmune conditions, where the immune system mistakenly attacks the body. The company is working on two experimental drugs targeting a range of serious diseases, including rheumatoid arthritis, lupus, and several rare neurological and eye conditions. Founded in 2018, Immunovant operates as part of Roivant Sciences.
